Hrvoje Miletić

Haukeland University Hospital — Norway

Medicine · Health Sciences

51h-index11.0kcitations293works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(112), Virus-based gene therapy research(33), Cancer, Hypoxia, and Metabolism(30), Brain Metastases and Treatment(19), Epigenetics and DNA Methylation(18)

Publications290 total

Mitochondria transfer in Glioblastoma
Neuro-Oncology·2026Open Access
Tropism Profiling of Lentiviral Vector Pseudotypes in Diverse Brain Tumor Models
Pharmaceutics·2026Open Access
Co-delivery of panobinostat and siSTAT3 using engineered M1 exosomes to establish a one-two punch therapeutic strategy for glioblastoma recurrence
Materials Today Bio·2025Open Access
Development of a highly differentiated rat brain organoid model for exploring glioblastoma invasion dynamics and therapy
Neuro-Oncology·2025· 1 citedOpen Access
TMIC-93. TGF-β facilitated mitochondria transfer in glioblastoma enhances tumor invasion and formate overflow
Neuro-Oncology·2025Open Access
Gasdermin E in glioblastoma –pyroptosis resistance and tumor-promoting functions
Cell Death Discovery·2025· 1 citedOpen Access
Predictive modeling of glioblastoma recurrence for therapeutic target identification
EMBO Molecular Medicine·2025Open Access
Abstract 4505: Differential protein expression in platelets collected from glioma patients and healthy controls: A comparative study
Cancer Research·2025
Use of psychotropic medications among glioma patients in Denmark, Norway, Sweden, and Wales
Journal of Neuro-Oncology·2025Open Access
A Medical Rarity: Isolated <i>Toxoplasma gondii</i> Abscess in the Pituitary Gland of an Immunocompetent Patient
Case Reports in Infectious Diseases·2025· 1 citedOpen Access
CTNI-44. NCT03643549 PHASE IB/II TRIAL: EFFICACY, SAFETY, AND BIOLOGICAL MECHANISMS OF OBJECTIVE RESPONSES IN RECURRENT GBM PATIENTS WITH UNMETHYLATED MGMT PROMOTER TREATED WITH SEQUENTIAL BORTEZOMIB AND TEMOZOLOMIDE
Neuro-Oncology·2024Open Access
OS03.6.A MITOCHONDRIA TRANSFER IN GBM IS MEDIATED BY TGF-Β AND PROMOTES INCREASED INVASIVENESS
Neuro-Oncology·2024· 1 citedOpen Access
Abstract CT019: Biological mechanisms underlying objective responses in recurrent GBM patients treated with sequential bortezomib and temozolomide: An interim analysis of NCT03643549 Phase IB/II trial
Cancer Research·2024
Table S3 from The Epigenetic Evolution of Glioma Is Determined by the &lt;i&gt;IDH1&lt;/i&gt; Mutation Status and Treatment Regimen
2024Open Access
Table S2 from The Epigenetic Evolution of Glioma Is Determined by the &lt;i&gt;IDH1&lt;/i&gt; Mutation Status and Treatment Regimen
2024Open Access
Table S2 from The Epigenetic Evolution of Glioma Is Determined by the &lt;i&gt;IDH1&lt;/i&gt; Mutation Status and Treatment Regimen
2024Open Access
Table S5 from The Epigenetic Evolution of Glioma Is Determined by the &lt;i&gt;IDH1&lt;/i&gt; Mutation Status and Treatment Regimen
2024Open Access
Table S3 from The Epigenetic Evolution of Glioma Is Determined by the &lt;i&gt;IDH1&lt;/i&gt; Mutation Status and Treatment Regimen
2024Open Access
Supplementary Appendix from The Epigenetic Evolution of Glioma Is Determined by the &lt;i&gt;IDH1&lt;/i&gt; Mutation Status and Treatment Regimen
2024Open Access
Table S6 from The Epigenetic Evolution of Glioma Is Determined by the &lt;i&gt;IDH1&lt;/i&gt; Mutation Status and Treatment Regimen
2024Open Access
page 1 of 15Next →

Frequent Co-authors

Rolf Bjerkvig(27), Simone P. Niclou(13), Jian Wang(10), Thomas Daubon(8), Olivier Keunen(7), Frits Thorsen(7), Per Øyvind Enger(7), Daniel Stieber(6), Per Øystein Sakariassen(6), Gro Vatne Røsland(6), Patrick N. Harter(6), Frank Winkler(5), Morten Lund‐Johansen(5), Eskil Eskilsson(5), Andreas H. Jacobs(5), Peter C. Huszthy(5), Charalampos Tzoulis(5), Christel Herold‐Mende(5), Jubayer A. Hossain(5), Michel Mittelbronn(5)